Federal Supply Schedule V797D40157

Award Date 5/1/14
Last Date to Order 1/31/25
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Fixed Price with Economic Price Adjustment
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed
Similar IDVs
This Federal Supply Schedule contract, awarded by the Department of Veterans Affairs (VA) to Apotex Corp., provides for the delivery of 65 I B, Drugs, Pharmaceuticals, & Hematology Related Products. The contract has a ceiling value of $23,375,390.00 and a period of performance running from September 15, 2024 through September 14, 2029. As a Federal Supply Schedule (FSS) contract, this is a multiple award vehicle that allows federal agencies to procure the specified pharmaceutical and related...
This Federal Supply Schedule contract, awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian federal agency, is for the procurement of drugs, pharmaceuticals, and hematology-related products. The prime contractor is Validus Pharmaceuticals, LLC, a for-profit limited liability company that manufactures goods. The contract has a ceiling value of $2,420,310.00 and a period of performance from April 1, 2023 to March 31, 2028. As a Federal Supply Schedule contract, it is a...
This federal contract IDV award is a Federal Supply Schedule (FSS) contract with the Department of Veterans Affairs (VA), specifically the Veterans Integrated Service Network 12 (VISN 12). The contract provides for the delivery of pharmaceutical and drug products, as well as hematology-related products, with a total ceiling value of $444,187.20. The contract was awarded to R-Pharm US LLC, a for-profit manufacturer, on September 1, 2016, with a period of performance through March 31, 2026. The...
This federal contract IDV is a Federal Supply Schedule (FSS) Contract awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency under the U.S. Department of Veterans Affairs. The contract was awarded to Methapharm Inc., a foreign-owned for-profit organization, on April 1, 2022, with an ultimate completion date of December 31, 2027 and a ceiling value of $811,760.00. The contract falls under the Pharmaceuticals and Drugs (FSS-61-IB) master schedule and is for the...
The Federal Supply Schedule contract is awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency of the U.S. federal government. The contract, valued up to $1,155,030.00, has an ultimate completion date of August 31, 2029 and was awarded to Soleva Pharma LLC, a for-profit limited liability company, on September 1, 2024. The contract is for the procurement of 65 I B, DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS for VISN 12. As a Federal Supply Schedule...
The Federal Supply Schedule contract (ID: 36F79723D0238) was awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency, to Mylan Institutional LLC, a for-profit limited liability company manufacturer of goods. The contract is for the procurement of drugs, pharmaceuticals, and hematology-related products, with a ceiling value of $94,000,000 and a period of performance from September 29, 2023, to September 28, 2028. The contract was awarded without any set-asides and on...
This Federal Supply Schedule contract, awarded by the Veterans Integrated Service Network 12 (VISN 12), is for the procurement of drugs, pharmaceuticals, and hematology-related products (FSS Contract 65 I B). The $330,000,000 multiple-award contract has a period of performance from October 1, 2023 to September 30, 2028. The prime contractor for this IDV is Acadia Pharmaceuticals Inc., a self-certified small disadvantaged business. The contract aims to provide VISN 12, a civilian federal...
The Federal Supply Schedule contract award 36F79719D0259 was issued by the Veterans Integrated Service Network 12 (VISN 12), a civilian federal agency, to the prime contractor Antares Pharma Inc. The contract, categorized under FSS-61-IB for Pharmaceuticals and Drugs, has a ceiling value of $8,334,100.00 and a period of performance through September 14, 2025. The contract aims to procure a range of drugs, pharmaceuticals, and hematology-related products from the manufacturer Antares Pharma...
This is a Federal Supply Schedule contract awarded by the Veterans Integrated Service Network 12 (VISN 12) to Ajanta Pharma USA Inc. The contract is for INTERIM AGREEMENT UNDER FSS SCHEDULE 65 I B DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS, with a ceiling value of $25,000.00 and a period of performance from December 2, 2024 to May 31, 2025. As a Federal Supply Schedule contract, this vehicle allows VISN 12, which is a civilian federal agency, to procure pharmaceutical and...
This federal contract IDV is a Federal Supply Schedule award by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency of the U.S. government. The contract was awarded to Shionogi Inc., a foreign-owned, for-profit manufacturer, on September 1, 2023, with a ceiling value of $12,526,636.00 and a period of performance through August 31, 2028. The contract is for the provision of "DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS" under FSS Contract 65 I B. The...

This Federal Supply Schedule contract IDV was awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency, to Apotex Corp. The contract has a total ceiling value of $38,000,000.00 and a period of performance through January 31, 2025.

The contract is for the provision of DRUGS, PHARMACEUTICALS & HEMATOLOGY RELATED PRODUCTS (FSS-61-IB) to support the healthcare needs of VISN 12. As a Federal Supply Schedule, this is a multiple award contract that allows federal agencies to procure these pharmaceutical products and related services. The contract does not utilize any set-asides. The prime contractor, Apotex Corp, is a for-profit organization registered in the System for Award Management (SAM) through July 2025.

Generated 8/20/24, 9:08 AM